Invention Grant
US08481541B2 Pyrrolopyrazine kinase inhibitors 失效
吡咯吡嗪激酶抑制剂

Pyrrolopyrazine kinase inhibitors
Abstract:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q, R2, R3, and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
Public/Granted literature
Information query
Patent Agency Ranking
0/0